Metro Inc

Latest Results (12.11.2025):

Metro Inc's 3rd Quarter 2025 financial results demonstrate solid performance with rising sales and earnings. The company reported total sales of $6,871.0 million, a 3.3% increase over the prior year, alongside improved net earnings of $323.0 million (up 9.0%) and fully diluted net earnings per share of $1.48 (up 13.0%). Enhanced same-store sales in both the food (up 1.9%) and pharmacy (up 5.5%) segments, along with controlled operating expenses and productivity gains, drove these results and underline Metro Inc's strategic initiatives and ongoing investments in its retail network.

Sales & Earnings

Metro Inc's total sales for Q3 2025 reached $6,871.0 million, up 3.3% from Q3 2024. Net earnings improved to $323.0 million (a 9.0% increase) and fully diluted net earnings per share rose to $1.48 (up 13.0%), with adjusted figures showing a similar encouraging trend.

Same-Store Sales Performance

The company reported food same-store sales up by 1.9% and pharmacy same-store sales up by 5.5% compared to the prior year. These gains, combined with positive movements in prescription drugs and front-store sales, highlight strong consumer demand across key segments.

Operating Income & Cost Control

Operating income before depreciation and amortization improved to $655.7 million, representing 9.5% of sales—up 5.7% year-over-year. Enhanced margins, improved productivity at food distribution centers, and cost control measures contributed to these favorable results.

Dividend & Continued Investment

Metro Inc declared a quarterly dividend of $0.37 per share on August 12, 2025, matching the previous quarter's payout. The results underscore the company's commitment to shareholder returns and its strategy to further drive growth through strategic store openings and long-term investments in its supply chain and retail network.